Reata Pharmaceuticals Inc

Swiss National Bank

Report date

6/30/2023

Quarter

2023 Q2

Filed

8/9/2023

Shares

52,400

Value ($000)

5,343

Weight

0.0%

2019 Q4 - 2023 Q2 (15 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q2	8/9/2023	5,343	0.0%	52,400	6/30/2023
2023 Q1	5/10/2023	5,292	0.0%	58,200	3/31/2023
2022 Q4	2/8/2023	2,462	0.0%	64,800	12/31/2022
2022 Q3	11/9/2022	1,591	0.0%	63,300	9/30/2022
2022 Q2	8/9/2022	1,924	0.0%	63,300	6/30/2022
2022 Q1	5/9/2022	2,074	0.0%	63,300	3/31/2022
2021 Q4	2/8/2022	1,553	0.0%	58,900	12/31/2021
2021 Q3	11/8/2021	5,926	0.0%	58,900	9/30/2021
2021 Q2	8/6/2021	8,237	0.0%	58,200	6/30/2021
2021 Q1	5/7/2021	5,583	0.0%	56,000	3/31/2021
2020 Q4	2/5/2021	6,787	0.0%	54,900	12/31/2020
2020 Q3	11/9/2020	5,290	0.0%	54,300	9/30/2020
2020 Q2	8/5/2020	8,269	0.0%	53,000	6/30/2020
2020 Q1	5/8/2020	6,077	0.0%	42,100	3/31/2020
2019 Q4	2/6/2020	7,666	0.0%	37,500	12/31/2019